<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          Global EditionASIA 中文雙語Fran?ais
          Opinion
          Home / Opinion / Global Lens

          AI sparking a global health revolution

          By Roland Eils and Gu Lei | China Daily | Updated: 2025-05-28 06:52
          Share
          Share - WeChat
          MA XUEJING/CHINA DAILY

          Imagine a world where diseases are spotted before they strike, health is monitored by a digital guardian and treatments are perfectly tailored. This is no longer a distant dream but an emerging reality supercharged by artificial intelligence, big data and digital health. These technologies are rewriting global public health, offering a more reliable way to better predict illnesses, closely monitor people's well-being, treat them with pinpoint accuracy, and make healthcare fairer and faster. To achieve this, we need a strong, equitable worldwide healthcare system.

          Think of AI and big data as health super-sleuths. They sift through mountains of health data, spotting patterns humans might miss, making disease prediction sharper. The large language model of DeepSeek shows promise in understanding medical conversations and helping doctors read scans for early signs of trouble, which means quicker help and access to fairer medical knowhow.

          AI analysis of electronic health records can flag risks which can lead to hundreds of diseases later in life and years before the onset of the disease. This is vital for spotting individuals vulnerable to diseases during health scares. A simple, cheap AI-read eye scan could soon predict the risks for many conditions including type 2 diabetes, making large-scale, cost-effective early disease detection feasible.

          AI-powered wearables and health apps are becoming personal health coaches, tracking body signals, lifestyle and the environment to warn of risks and offer tailored advice. AI analysis of our unique chemical signature readily obtained from a single blood draw can predict multi-disease risk and track health in detail. This proactive approach is key to chronic disease control and boosting health literacy.

          AI also personalizes treatment. By crunching patient data and medical studies, AI can help understand diseases, find new drug targets and predict treatment responses. It can spot patient subgroups who will respond best to specific therapies and help expedite the discovery of new medicines and testing methods, making access to life-saving drugs faster.

          AI, big data and digital health technologies are transforming healthcare, making it more efficient, accessible and equitable. By automating administrative tasks, optimizing hospital work-flows, and supporting faster, more accurate diagnoses, AI reduces the burden on medical workers and shortens patients' wait time. Advanced large language models such as DeepSeek can provide expert-level medical support for remote and underserved regions, helping bridge the gap in access to quality medical care.

          These innovations play a vital role in addressing global healthcare disparities. Low-cost AI-powered health apps and virtual consultations extend high-quality medical services to communities with limited resources. When trained on diverse medical data, AI systems offer accurate predictions for a wide range of population groups, including those historically underrepresented. Affordable diagnostic tools, such as AI-analyzed retinal scans and chemical signature tests, further democratize access to vital health information, paving the way for more inclusive and proactive healthcare worldwide.

          While the promise of AI in healthcare is immense, ensuring its safe, ethical and equitable use requires thoughtful regulation. Regulations for AI in healthcare markedly differs across the European Union, the United States and China. The EU leads with its comprehensive AI Act, classifying health-related AI as high-risk, and requiring strict oversight and compliance. Its General Data Protection Regulation enforces rigorous data privacy, emphasizing individual rights and explicit consent.

          The US lacks a unified AI law, relying on the FDA for case-by-case regulation for AI in healthcare, and the Health Insurance Portability and Accountability Act for data privacy, which is less stringent than the EU's GDPR.

          China, on the other hand, has adopted a strategic, State-guided approach, embedding AI governance within broader national frameworks. While it has no standalone AI law, it issues detailed ethical guidelines and uses the Personal Information Protection Law to regulate health data, emphasizing consent and data localization.

          These different models — the EU's rights-based, the US' innovation-driven, and China's State-coordinated — reflect distinct policy priorities and cultural values shaping the global landscape of AI in healthcare. Given China's rapid pace of AI innovation and strong State coordination, the country is well positioned to accelerate the use of AI-driven healthcare solutions from urban centers to remote rural areas.

          In doing so, China can serve as a global role model by demonstrating how digital health technologies can promote equity and transform public health at scale. We are entering a new era of data-driven, AI-enabled public health. To seize the opportunities offered by this advancement, we need global cooperation, interdisciplinary research and shared ethical principles. By embracing these technologies responsibly and inclusively, we can build a smarter, fairer and healthier world for all.

          Roland Eils is a member of Leopoldina National Academy of Sciences, Germany and is promoting AI healthcare applications in Berlin and Shanghai.
          Gu Lei is a principal investigator, exploring environmental-genetic interactions with the integration of AI at the Max Planck Institute for Heart and Lung Research.

          The views don't necessarily reflect those of China Daily.

          If you have a specific expertise, or would like to share your thought about our stories, then send us your writings at opinion@chinadaily.com.cn, and comment@chinadaily.com.cn.

          Most Viewed in 24 Hours
          Top
          BACK TO THE TOP
          English
          Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          主站蜘蛛池模板: 一区二区亚洲人妻av| 国产精品原创不卡在线| 亚洲老妇女一区二区三区| 麻豆精品久久久久久久99蜜桃| 欧美激情综合色综合啪啪五月| 熟妇人妻无码中文字幕老熟妇| 50岁人妻丰满熟妇αv无码区| 熟女国产精品一区二区三| 国产99re热这里只有精品| 色综合久久久久综合体桃花网| 亚洲精品动漫免费二区| 国产成人99亚洲综合精品 | 国产一卡2卡3卡4卡网站精品| 精品国产免费第一区二区三区日韩| 国产不卡一区二区在线视频| 一本无码在线观看| 亚洲の无码国产の无码步美| 99999久久久久久亚洲| 无码人妻av免费一区二区三区| 日本怡春院一区二区三区| 亚洲国产精品综合久久网各| 男人的天堂av社区在线| 无码人妻视频一区二区三区| 国内不卡不区二区三区| 97精品依人久久久大香线蕉97 | 亚洲欧美人成电影在线观看| 一本久久a久久免费精品不卡| 国产精品自拍实拍在线看| 一个人看的www在线视频| 国产精品国产三级国产试看| 免费国产一级 片内射老| 国产美女在线观看大长腿| 丝袜a∨在线一区二区三区不卡 | 自拍亚洲综合在线精品| 免费无码一区二区三区蜜桃大| 久9re热视频这里只有精品免费| 国产精品一区高清在线观看| 极品蜜臀黄色在线观看| 一区二区和激情视频| 少妇精品视频一码二码三| 综合色一色综合久久网|